IL-21 Is an Antitolerogenic Cytokine of the Late-Phase Alloimmune Response
- Author
- PETRELLI, Alessandra1 2 ; CARVELLO, Michele3 4 ; SECCHI, Antonio2 ; LEONARD, Warren J7 ; YOUNG, Deborah8 ; SAYEGH, Mohamed H1 ; MARKMANN, James F3 ; ZAJAC, Allan J5 ; FIORINA, Paolo1 2 ; VERGANI, Andrea1 2 ; KANG MI LEE3 ; TEZZA, Sara1 ; MING DU5 ; KLEFFEL, Sonja1 ; CHENGWEN, Liu6 ; MFARREJ, Bechara G1 ; HWU, Patrick6
[1] Transplantation Research Center, Children's Hospital, Harvard Medical School, Boston, Massachusetts, United States
[2] Department of Medicine, San Raffaele Scientific Institute, Milan, Italy
[3] Transplant Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States
[4] Gastrointestinal Surgery, San Raffaele Scientific Institute, Milan, Italy
[5] Department of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama, United States
[6] Department of Melanoma Medical Oncology, Center for Cancer Immunology Research, University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States
[7] Laboratory of Molecular Immunology, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States
[8] Immunology and Inflammation, Pfizer, Cambridge, Massachusetts, United States - Source
Diabetes (New York, NY). 2011, Vol 60, Num 12, pp 3223-3234, 12 p ; ref : 40 ref
- CODEN
- DIAEAZ
- ISSN
- 0012-1797
- Scientific domain
- Endocrinology; Nutrition, obesity, metabolic disorders
- Publisher
- American Diabetes Association, Alexandria, VA
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Cytokine Diabète Endocrinopathie
- Keyword (en)
- Cytokine Diabetes mellitus Endocrinopathy
- Keyword (es)
- Citoquina Diabetes Endocrinopatía
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B21 Endocrinopathies / 002B21E Endocrine pancreas. Apud cells (diseases) / 002B21E01 Diabetes. Impaired glucose tolerance / 002B21E01A Etiopathogenesis. Screening. Investigations. Target tissue resistance
- Discipline
- Endocrinopathies
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 25273955
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.2337/db11-0880 
https://dx.doi.org/10.2337/db11-0880
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.2337\/db11-0880\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:74:\"IL-21 Is an Antitolerogenic Cytokine of the Late-Phase Alloimmune Response\";s:9:\"\u0000*\u0000jtitle\";s:23:\"Diabetes (New York, NY)\";s:9:\"\u0000*\u0000stitle\";s:18:\"Diabetes (N.Y. NY)\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"60\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:4:\"3223\";s:8:\"\u0000*\u0000epage\";s:4:\"3234\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0012-1797\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"PETRELLI\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Alessandra\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:17:\"CARVELLO, Michele\";i:1;s:15:\"SECCHI, Antonio\";i:2;s:17:\"LEONARD, Warren J\";i:3;s:14:\"YOUNG, Deborah\";i:4;s:17:\"SAYEGH, Mohamed H\";i:5;s:17:\"MARKMANN, James F\";i:6;s:14:\"ZAJAC, Allan J\";i:7;s:14:\"FIORINA, Paolo\";i:8;s:15:\"VERGANI, Andrea\";i:9;s:11:\"KANG MI LEE\";i:10;s:11:\"TEZZA, Sara\";i:11;s:7:\"MING DU\";i:12;s:14:\"KLEFFEL, Sonja\";i:13;s:13:\"CHENGWEN, Liu\";i:14;s:18:\"MFARREJ, Bechara G\";i:15;s:12:\"HWU, Patrick\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"DIAEAZ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:74:\"IL-21 Is an Antitolerogenic Cytokine of the Late-Phase Alloimmune Response\";s:8:\"\u0000*\u0000place\";s:14:\"Alexandria, VA\";s:6:\"\u0000*\u0000pub\";s:29:\"American Diabetes Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"12\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.2337\/db11-0880\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:74:\"IL-21 Is an Antitolerogenic Cytokine of the Late-Phase Alloimmune Response\";s:9:\"\u0000*\u0000jtitle\";s:23:\"Diabetes (New York, NY)\";s:9:\"\u0000*\u0000stitle\";s:18:\"Diabetes (N.Y. NY)\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"60\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:4:\"3223\";s:8:\"\u0000*\u0000epage\";s:4:\"3234\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0012-1797\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"PETRELLI\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Alessandra\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:17:\"CARVELLO, Michele\";i:1;s:15:\"SECCHI, Antonio\";i:2;s:17:\"LEONARD, Warren J\";i:3;s:14:\"YOUNG, Deborah\";i:4;s:17:\"SAYEGH, Mohamed H\";i:5;s:17:\"MARKMANN, James F\";i:6;s:14:\"ZAJAC, Allan J\";i:7;s:14:\"FIORINA, Paolo\";i:8;s:15:\"VERGANI, Andrea\";i:9;s:11:\"KANG MI LEE\";i:10;s:11:\"TEZZA, Sara\";i:11;s:7:\"MING DU\";i:12;s:14:\"KLEFFEL, Sonja\";i:13;s:13:\"CHENGWEN, Liu\";i:14;s:18:\"MFARREJ, Bechara G\";i:15;s:12:\"HWU, Patrick\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"DIAEAZ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:74:\"IL-21 Is an Antitolerogenic Cytokine of the Late-Phase Alloimmune Response\";s:8:\"\u0000*\u0000place\";s:14:\"Alexandria, VA\";s:6:\"\u0000*\u0000pub\";s:29:\"American Diabetes Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"12\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:17:\"10.2337\/db11-0880\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.2337\/db11-0880\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:74:\"IL-21 Is an Antitolerogenic Cytokine of the Late-Phase Alloimmune Response\";s:9:\"\u0000*\u0000jtitle\";s:23:\"Diabetes (New York, NY)\";s:9:\"\u0000*\u0000stitle\";s:18:\"Diabetes (N.Y. NY)\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"60\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:4:\"3223\";s:8:\"\u0000*\u0000epage\";s:4:\"3234\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0012-1797\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"PETRELLI\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Alessandra\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:17:\"CARVELLO, Michele\";i:1;s:15:\"SECCHI, Antonio\";i:2;s:17:\"LEONARD, Warren J\";i:3;s:14:\"YOUNG, Deborah\";i:4;s:17:\"SAYEGH, Mohamed H\";i:5;s:17:\"MARKMANN, James F\";i:6;s:14:\"ZAJAC, Allan J\";i:7;s:14:\"FIORINA, Paolo\";i:8;s:15:\"VERGANI, Andrea\";i:9;s:11:\"KANG MI LEE\";i:10;s:11:\"TEZZA, Sara\";i:11;s:7:\"MING DU\";i:12;s:14:\"KLEFFEL, Sonja\";i:13;s:13:\"CHENGWEN, Liu\";i:14;s:18:\"MFARREJ, Bechara G\";i:15;s:12:\"HWU, Patrick\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"DIAEAZ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:74:\"IL-21 Is an Antitolerogenic Cytokine of the Late-Phase Alloimmune Response\";s:8:\"\u0000*\u0000place\";s:14:\"Alexandria, VA\";s:6:\"\u0000*\u0000pub\";s:29:\"American Diabetes Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"12\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.2337\/db11-0880\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:74:\"IL-21 Is an Antitolerogenic Cytokine of the Late-Phase Alloimmune Response\";s:9:\"\u0000*\u0000jtitle\";s:23:\"Diabetes (New York, NY)\";s:9:\"\u0000*\u0000stitle\";s:18:\"Diabetes (N.Y. NY)\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"60\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:4:\"3223\";s:8:\"\u0000*\u0000epage\";s:4:\"3234\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0012-1797\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"PETRELLI\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Alessandra\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:17:\"CARVELLO, Michele\";i:1;s:15:\"SECCHI, Antonio\";i:2;s:17:\"LEONARD, Warren J\";i:3;s:14:\"YOUNG, Deborah\";i:4;s:17:\"SAYEGH, Mohamed H\";i:5;s:17:\"MARKMANN, James F\";i:6;s:14:\"ZAJAC, Allan J\";i:7;s:14:\"FIORINA, Paolo\";i:8;s:15:\"VERGANI, Andrea\";i:9;s:11:\"KANG MI LEE\";i:10;s:11:\"TEZZA, Sara\";i:11;s:7:\"MING DU\";i:12;s:14:\"KLEFFEL, Sonja\";i:13;s:13:\"CHENGWEN, Liu\";i:14;s:18:\"MFARREJ, Bechara G\";i:15;s:12:\"HWU, Patrick\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"DIAEAZ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:74:\"IL-21 Is an Antitolerogenic Cytokine of the Late-Phase Alloimmune Response\";s:8:\"\u0000*\u0000place\";s:14:\"Alexandria, VA\";s:6:\"\u0000*\u0000pub\";s:29:\"American Diabetes Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"12\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.2337\/db11-0880\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:74:\"IL-21 Is an Antitolerogenic Cytokine of the Late-Phase Alloimmune Response\";s:9:\"\u0000*\u0000jtitle\";s:23:\"Diabetes (New York, NY)\";s:9:\"\u0000*\u0000stitle\";s:18:\"Diabetes (N.Y. NY)\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"60\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:4:\"3223\";s:8:\"\u0000*\u0000epage\";s:4:\"3234\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0012-1797\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"PETRELLI\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Alessandra\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:17:\"CARVELLO, Michele\";i:1;s:15:\"SECCHI, Antonio\";i:2;s:17:\"LEONARD, Warren J\";i:3;s:14:\"YOUNG, Deborah\";i:4;s:17:\"SAYEGH, Mohamed H\";i:5;s:17:\"MARKMANN, James F\";i:6;s:14:\"ZAJAC, Allan J\";i:7;s:14:\"FIORINA, Paolo\";i:8;s:15:\"VERGANI, Andrea\";i:9;s:11:\"KANG MI LEE\";i:10;s:11:\"TEZZA, Sara\";i:11;s:7:\"MING DU\";i:12;s:14:\"KLEFFEL, Sonja\";i:13;s:13:\"CHENGWEN, Liu\";i:14;s:18:\"MFARREJ, Bechara G\";i:15;s:12:\"HWU, Patrick\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"DIAEAZ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:74:\"IL-21 Is an Antitolerogenic Cytokine of the Late-Phase Alloimmune Response\";s:8:\"\u0000*\u0000place\";s:14:\"Alexandria, VA\";s:6:\"\u0000*\u0000pub\";s:29:\"American Diabetes Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"12\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
